A group of 45 senior industry figures, including in-house procurement officers, have been invited to participate in the debate to be held at GlaxoSmithKline premises and managed by the AHC’s evaluation sub-committee, as the next stage of the association’s Evaluation Toolkit, launched last year. Heads of the IPR and PRCA have also been invited.
Sub-committee member and Red Door Communications MD Catherine Warne said: ‘This is not an issue that can be solved with an easy fix. It requires careful thought.’
A benchmarking survey on the subject is being drafted to generate quantitative data which, together with the results of the debate, will produce a discussion paper for wider consultation.